Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Arthritis, Rheumatoid 6Spondylitis, Ankylosing 2Psoriasis 2Crohn Disease 2Colitis, Ulcerative 2Uveal Melanoma 1Plaque Psoriasis 1Melanoma 1Hidradenitis Suppurativa 1Healthy Adult Male 1Healthy 1Acne Vulgaris 1Abscess 1

Interventions

Adalimumab 2tocilizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Spondylitis, Ankylosing × Adalimumab × Clear all
NCT02893254 2018-06-04

Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis

Innovent Biologics (Suzhou) Co. Ltd.

Phase 3 Completed
438 enrolled

Spondylitis, Ankylosing

NCT00085644 2011-04-21

ATLAS

Abbott

Phase 3 Completed
315 enrolled 45 charts

Spondylitis, Ankylosing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡